Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2016 Jun 22;22(9):1636–1645. doi: 10.1016/j.bbmt.2016.06.012

Table 4.

Results of multivariable analysis for risk of bacterial, fungal, and viral infections

Variable Bacterial Infections
RR (95% CI)
p-value Fungal Infections
RR (95% CI)
p-value Viral Infections
RR (95% CI)
p-value

Main Effect <0.0001 0.0002 <0.0001
MUD 1.00 1.00 1.00
MMUD 1.196(1.018–1.406) 0.0295 1.377(1.013–1.872) 0.0413 1.283(1.072–1.535) 0.0067
UCB* 1.609(1.414–1.831) <0.001 1.654(1.301 −2.102) <0.0001 2.281 (1.989–2.615) <0.0001

Acute GVHD, yes 1.360(1.163–1.589) 0.0001

Chronic GVHD, yes 1.490(1.152–1.928) 0.0024

Conditioning regimen
(< 3 mo)
<0.0001
MAC 1.00
NMA/RIC 0.588 (0.505 – 0.683)

Conditioning regimen
(> 3 mo)
0.9030
MAC 1.00
NMA/RIC 1.016(0.791 −1.304)

Year of Transplant 0.0226
2008 – 2009 1.00
2010–2011 0.938(0.888–0.991)

ATG, yes 1.604(1.400–1.838) <0.0001

CMV D/R match <0.0001
Neg/Neg 1.00
Any positive 1.629(1.413–1.878) <0.001
Missing 0.802(0.378–1.701) 0.5647

Conditioning 0.0002
Regimen 1.00
MAC 0.768 (0.667 – 0.883)
NMA/RIC

GVHD 0.0001
aGVHD no, cGVHD no 1.00
aGVHD yes, cGVHD no 1.863(1.601 −2.167) <0.0001
aGVHD no, cGVHD yes 2.331 (1.64–3.317) <0.0001
aGVHD yes, cGVHD yes 1.855(1.259–2.733) 0.0018
*

Contrast MMUD vs UCB: Bacterial, 0.74 (0.62–0.88), p<0.001; Fungal, 0.83 (0.61 – 1.14), p=0.26; Viral, 0.56 (0.47 – 0.68), p<0.0001

Contrast: aGVHD yes, cGVHD no vs aGVHD no, cGVHD yes, 0.799 (0.559 – 1.14), p = 0.218; aGVHD yes, cGVHD no vs aGVHD yes, 1.004 (0.680 – 1.481), p=0.984; aGVHD no, cGVHD yes vs. aGVHD yes, cGVHD yes, 1.256 (0.834 – 1.892), p=0.275